# Oxybutynin Chloride in Managing Hot Flashes

> **NCT02961790** · PHASE3 · COMPLETED · sponsor: **Academic and Community Cancer Research United** · enrollment: 150 (actual)

## Conditions studied

- Breast Carcinoma
- Ductal Breast Carcinoma In Situ
- Hot Flashes
- Lobular Breast Carcinoma In Situ
- No Evidence of Disease

## Interventions

- **DRUG:** Oxybutynin Chloride
- **OTHER:** Placebo
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT02961790
- **Lead sponsor:** Academic and Community Cancer Research United
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-09
- **Primary completion:** 2018-04-27
- **Final completion:** 2018-04-27
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02961790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02961790, "Oxybutynin Chloride in Managing Hot Flashes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02961790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*